• 501 Citations
  • 5 h-Index
20162018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Domenico Franco Merlo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Sarcoma Medicine & Life Sciences
Multicenter Studies Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
fotemustine Medicine & Life Sciences
MicroRNAs Medicine & Life Sciences
Rheiformes Medicine & Life Sciences
Down-Regulation Medicine & Life Sciences
Ifosfamide Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2016 2018

  • 501 Citations
  • 5 h-Index
  • 13 Article
1 Citation (Scopus)

Mortality among workers exposed to asbestos at the shipyard of Genoa, Italy: A 55 years follow-up

Merlo, D. F., Bruzzone, M., Bruzzi, P., Garrone, E., Puntoni, R., Maiorana, L. & Ceppi, M., Dec 29 2018, In : Environmental Health: A Global Access Science Source. 17, 1, 94.

Research output: Contribution to journalArticle

Asbestos
Italy
Mortality
Lung Neoplasms
Mesothelioma

Mortality among workers exposed to asbestos at the shipyard of Genoa, Italy: A 55 years follow-up

Merlo, D. F., Bruzzone, M., Bruzzi, P., Garrone, E., Puntoni, R., Maiorana, L. & Ceppi, M., 2018, In : Environmental Health: A Global Access Science Source. 17, 1

Research output: Contribution to journalArticle

Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma

Truini, A., Coco, S., Nadal, E., Genova, C., Mora, M., Dal Bello, M. G., Vanni, I., Alama, A., Rijavec, E., Biello, F., Barletta, G., Merlo, D. F., Valentino, A., Ferro, P., Ravetti, G. L., Stigliani, S., Vigani, A., Fedeli, F., Beer, D. G., Roncella, S. & 1 others, Grossi, F., Sep 15 2017, In : Oncotarget. 8, 40, p. 68627-68640 14 p.

Research output: Contribution to journalArticle

MicroRNAs
Down-Regulation
Survival
Malignant Mesothelioma
Proportional Hazards Models

Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma

Truini, A., Coco, S., Nadal, E., Genova, C., Mora, M., Dal Bello, M. G., Vanni, I., Alama, A., Rijavec, E., Biello, F., Barletta, G., Merlo, D. F., Valentino, A., Ferro, P., Ravetti, G. L., Stigliani, S., Vigani, A., Fedeli, F., Beer, D. G., Roncella, S. & 1 others, Grossi, F., Sep 15 2017, In : Oncotarget. 8, 40, p. 68627-68640 14 p.

Research output: Contribution to journalArticle

MicroRNAs
Down-Regulation
Survival
Malignant Mesothelioma
Proportional Hazards Models
122 Citations (Scopus)

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

Gronchi, A., Ferrari, S., Quagliuolo, V., Broto, J. M., Pousa, A. L., Grignani, G., Basso, U., Blay, J. Y., Tendero, O., Beveridge, R. D., Ferraresi, V., Lugowska, I., Merlo, D. F., Fontana, V., Marchesi, E., Donati, D. M., Palassini, E., Palmerini, E., De Sanctis, R., Morosi, C. & 7 others, Stacchiotti, S., Bagué, S., Coindre, J. M., Dei Tos, A. P., Picci, P., Bruzzi, P. & Casali, P. G., Jun 1 2017, In : The Lancet Oncology. 18, 6, p. 812-822 11 p.

Research output: Contribution to journalArticle

Sarcoma
Multicenter Studies
Drug Therapy
Ifosfamide
Myxoid Liposarcoma